Overview: Fasting Glucose TestIntroduction: The Fasting Glucose Test measures fasting glucose to diagnose diabetes, causing thirst or fatigue. Following 2023 ADA guidelines, it uses spectrophotometry for high sensitivity, aiding in metabolic screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in biochemistry for patients with suspected diabetes. It is a cornerstone test for assessing glucose metabolism and identifying prediabetes or diabetes.
Other Names: Glucose Fasting Assay, Fasting Blood Sugar Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Fasting glucose testing began in the 1960s with diabetes research. Spectrophotometry advancements in the 1980s improved accuracy for metabolic screening.
Purpose: Diagnoses diabetes, guides treatment, and monitors fasting glucose levels in patients with thirst, fatigue, or frequent urination.
Test Parameters: 1. Glucose (Fasting)
Pretest Condition: Fasting for 10-12 hours required. Collect plasma or serum in the morning. Report symptoms like thirst, fatigue, or polyuria, and list medications.
Specimen: 2-4 mL plasma (NaF) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document thirst, fatigue, polyuria, or history of diabetes. Include current medications, especially antidiabetics, and family history.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for diabetes treatment or lifestyle changes.
Procedural Considerations: Uses spectrophotometry to measure fasting glucose levels. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, often part of a metabolic panel.
Factors Affecting Result Accuracy: Non-fasting, hemolysis, or medications (e.g., corticosteroids) can affect results. Stress or illness may alter glucose levels.
Clinical Significance: Elevated fasting glucose levels suggest prediabetes or diabetes, prompting treatment (e.g., insulin, lifestyle changes). Normal levels may require further testing to rule out diabetes.
Specialist Consultation: Consult an endocrinologist for result interpretation and diabetes management planning.
Additional Supporting Tests: OGTT, HbA1c, C-peptide, or fructosamine to confirm diabetes diagnosis.
Test Limitations: Fasting glucose alone may miss dynamic glucose changes. Results require clinical correlation and additional testing for accuracy.
References: ADA Diabetes Guidelines, 2023; Diabetes Care, Nathan DM, 2022.
